Wockhardt RX
FDA Approved Drugs

Wockhardt RX

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX
  • Total Records 31
  • Latest Approval Date May 29, 2026
  • Data Source FDA
  • First Approval Date Mar 28, 1997
All
120
View
Unclassified
5
View
Discontinued
83
View
OTC
1
View
RX
31
View
Company Overview

Company

Wockhardt RX

Country

India

Email

Social Profiles

LinkedIn
Company Snapshot

Wockhardt RX

Wockhardt Towers, Bandra Mumbai 400051 Maharashtra

India

www.wockhardt.com/ View on Map
FDA Approved Drug Records ( 31 records )
2019
27 Feb
RX Application: 208380

Drug Name

ABIRATERONE ACETATE

Product Number

1

Dosage Form

-

Strength

250MG

Approval Date

2019-02-27

208380 / 1

Active Ingredient

ABIRATERONE ACETATE

Application Number

208380

Product Number

1

Dosage Form

-

Strength

250MG

Approval Date

2019-02-27

Regulatory Status

RX

2012
21 Nov
RX Application: 202189

Drug Name

BUPROPION HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

2012-11-21

202189 / 1

Active Ingredient

BUPROPION HYDROCHLORIDE

Application Number

202189

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

2012-11-21

Regulatory Status

RX

2022
28 Jan
RX Application: 202189

Drug Name

BUPROPION HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

2022-01-28

202189 / 2

Active Ingredient

BUPROPION HYDROCHLORIDE

Application Number

202189

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

2022-01-28

Regulatory Status

RX

1997
28 Mar
RX Application: 74532

Drug Name

CAPTOPRIL

Product Number

1

Dosage Form

-

Strength

12.5MG

Approval Date

1997-03-28

74532 / 1

Active Ingredient

CAPTOPRIL

Application Number

74532

Product Number

1

Dosage Form

-

Strength

12.5MG

Approval Date

1997-03-28

Regulatory Status

RX

1997
28 Mar
RX Application: 74532

Drug Name

CAPTOPRIL

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

1997-03-28

74532 / 2

Active Ingredient

CAPTOPRIL

Application Number

74532

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

1997-03-28

Regulatory Status

RX

1997
28 Mar
RX Application: 74532

Drug Name

CAPTOPRIL

Product Number

3

Dosage Form

-

Strength

50MG

Approval Date

1997-03-28

74532 / 3

Active Ingredient

CAPTOPRIL

Application Number

74532

Product Number

3

Dosage Form

-

Strength

50MG

Approval Date

1997-03-28

Regulatory Status

RX

1997
28 Mar
RX Application: 74532

Drug Name

CAPTOPRIL

Product Number

4

Dosage Form

-

Strength

100MG

Approval Date

1997-03-28

74532 / 4

Active Ingredient

CAPTOPRIL

Application Number

74532

Product Number

4

Dosage Form

-

Strength

100MG

Approval Date

1997-03-28

Regulatory Status

RX

2007
12 Apr
RX Application: 65391

Drug Name

CEFTRIAXONE

Product Number

1

Dosage Form

-

Strength

EQ 250MG BASE/VIAL

Approval Date

2007-04-12

65391 / 1

Active Ingredient

CEFTRIAXONE SODIUM

Application Number

65391

Product Number

1

Dosage Form

-

Strength

EQ 250MG BASE/VIAL

Approval Date

2007-04-12

Regulatory Status

RX

2007
12 Apr
RX Application: 65391

Drug Name

CEFTRIAXONE

Product Number

2

Dosage Form

-

Strength

EQ 500MG BASE/VIAL

Approval Date

2007-04-12

65391 / 2

Active Ingredient

CEFTRIAXONE SODIUM

Application Number

65391

Product Number

2

Dosage Form

-

Strength

EQ 500MG BASE/VIAL

Approval Date

2007-04-12

Regulatory Status

RX

2007
12 Apr
RX Application: 65391

Drug Name

CEFTRIAXONE

Product Number

3

Dosage Form

-

Strength

EQ 2GM BASE/VIAL

Approval Date

2007-04-12

65391 / 3

Active Ingredient

CEFTRIAXONE SODIUM

Application Number

65391

Product Number

3

Dosage Form

-

Strength

EQ 2GM BASE/VIAL

Approval Date

2007-04-12

Regulatory Status

RX

1999
25 Oct
RX Application: 75346

Drug Name

CROMOLYN SODIUM

Product Number

1

Dosage Form

-

Strength

10MG/ML

Approval Date

1999-10-25

75346 / 1

Active Ingredient

CROMOLYN SODIUM

Application Number

75346

Product Number

1

Dosage Form

-

Strength

10MG/ML

Approval Date

1999-10-25

Regulatory Status

RX

2019
09 Apr
RX Application: 209056

Drug Name

DECITABINE

Product Number

1

Dosage Form

-

Strength

50MG/VIAL

Approval Date

2019-04-09

209056 / 1

Active Ingredient

DECITABINE

Application Number

209056

Product Number

1

Dosage Form

-

Strength

50MG/VIAL

Approval Date

2019-04-09

Regulatory Status

RX

2012
16 Aug
RX Application: 78941

Drug Name

ENTACAPONE

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2012-08-16

78941 / 1

Active Ingredient

ENTACAPONE

Application Number

78941

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2012-08-16

Regulatory Status

RX

2007
06 Aug
RX Application: 78137

Drug Name

FOSPHENYTOIN SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 50MG PHENYTOIN NA/ML

Approval Date

2007-08-06

78137 / 1

Active Ingredient

FOSPHENYTOIN SODIUM

Application Number

78137

Product Number

1

Dosage Form

-

Strength

EQ 50MG PHENYTOIN NA/ML

Approval Date

2007-08-06

Regulatory Status

RX

2007
19 Apr
RX Application: 78402

Drug Name

LISINOPRIL

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2007-04-19

78402 / 1

Active Ingredient

LISINOPRIL

Application Number

78402

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2007-04-19

Regulatory Status

RX

2007
19 Apr
RX Application: 78402

Drug Name

LISINOPRIL

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2007-04-19

78402 / 2

Active Ingredient

LISINOPRIL

Application Number

78402

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2007-04-19

Regulatory Status

RX

2007
19 Apr
RX Application: 78402

Drug Name

LISINOPRIL

Product Number

3

Dosage Form

-

Strength

10MG

Approval Date

2007-04-19

78402 / 3

Active Ingredient

LISINOPRIL

Application Number

78402

Product Number

3

Dosage Form

-

Strength

10MG

Approval Date

2007-04-19

Regulatory Status

RX

2007
19 Apr
RX Application: 78402

Drug Name

LISINOPRIL

Product Number

4

Dosage Form

-

Strength

20MG

Approval Date

2007-04-19

78402 / 4

Active Ingredient

LISINOPRIL

Application Number

78402

Product Number

4

Dosage Form

-

Strength

20MG

Approval Date

2007-04-19

Regulatory Status

RX

2007
19 Apr
RX Application: 78402

Drug Name

LISINOPRIL

Product Number

5

Dosage Form

-

Strength

30MG

Approval Date

2007-04-19

78402 / 5

Active Ingredient

LISINOPRIL

Application Number

78402

Product Number

5

Dosage Form

-

Strength

30MG

Approval Date

2007-04-19

Regulatory Status

RX

2007
19 Apr
RX Application: 78402

Drug Name

LISINOPRIL

Product Number

6

Dosage Form

-

Strength

40MG

Approval Date

2007-04-19

78402 / 6

Active Ingredient

LISINOPRIL

Application Number

78402

Product Number

6

Dosage Form

-

Strength

40MG

Approval Date

2007-04-19

Regulatory Status

RX

2010
22 Jul
RX Application: 90615

Drug Name

METOPROLOL SUCCINATE

Product Number

1

Dosage Form

-

Strength

EQ 25MG TARTRATE

Approval Date

2010-07-22

90615 / 1

Active Ingredient

METOPROLOL SUCCINATE

Application Number

90615

Product Number

1

Dosage Form

-

Strength

EQ 25MG TARTRATE

Approval Date

2010-07-22

Regulatory Status

RX

2010
22 Jul
RX Application: 90615

Drug Name

METOPROLOL SUCCINATE

Product Number

2

Dosage Form

-

Strength

EQ 50MG TARTRATE

Approval Date

2010-07-22

90615 / 2

Active Ingredient

METOPROLOL SUCCINATE

Application Number

90615

Product Number

2

Dosage Form

-

Strength

EQ 50MG TARTRATE

Approval Date

2010-07-22

Regulatory Status

RX

2010
22 Jul
RX Application: 90615

Drug Name

METOPROLOL SUCCINATE

Product Number

3

Dosage Form

-

Strength

EQ 100MG TARTRATE

Approval Date

2010-07-22

90615 / 3

Active Ingredient

METOPROLOL SUCCINATE

Application Number

90615

Product Number

3

Dosage Form

-

Strength

EQ 100MG TARTRATE

Approval Date

2010-07-22

Regulatory Status

RX

2010
22 Jul
RX Application: 90615

Drug Name

METOPROLOL SUCCINATE

Product Number

4

Dosage Form

-

Strength

EQ 200MG TARTRATE

Approval Date

2010-07-22

90615 / 4

Active Ingredient

METOPROLOL SUCCINATE

Application Number

90615

Product Number

4

Dosage Form

-

Strength

EQ 200MG TARTRATE

Approval Date

2010-07-22

Regulatory Status

RX

2006
26 Dec
RX Application: 77577

Drug Name

ONDANSETRON HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 2MG BASE/ML

Approval Date

2006-12-26

77577 / 1

Active Ingredient

ONDANSETRON HYDROCHLORIDE

Application Number

77577

Product Number

1

Dosage Form

-

Strength

EQ 2MG BASE/ML

Approval Date

2006-12-26

Regulatory Status

RX

2006
26 Dec
RX Application: 77716

Drug Name

ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE

Product Number

1

Dosage Form

-

Strength

EQ 2MG BASE/ML

Approval Date

2006-12-26

77716 / 1

Active Ingredient

ONDANSETRON HYDROCHLORIDE

Application Number

77716

Product Number

1

Dosage Form

-

Strength

EQ 2MG BASE/ML

Approval Date

2006-12-26

Regulatory Status

RX

2017
31 Jul
RX Application: 207147

Drug Name

OXACILLIN SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

2017-07-31

207147 / 1

Active Ingredient

OXACILLIN SODIUM

Application Number

207147

Product Number

1

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

2017-07-31

Regulatory Status

RX

2017
31 Jul
RX Application: 207147

Drug Name

OXACILLIN SODIUM

Product Number

2

Dosage Form

-

Strength

EQ 2GM BASE/VIAL

Approval Date

2017-07-31

207147 / 2

Active Ingredient

OXACILLIN SODIUM

Application Number

207147

Product Number

2

Dosage Form

-

Strength

EQ 2GM BASE/VIAL

Approval Date

2017-07-31

Regulatory Status

RX

2017
24 Nov
RX Application: 207148

Drug Name

OXACILLIN SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 10GM BASE/VIAL

Approval Date

2017-11-24

207148 / 1

Active Ingredient

OXACILLIN SODIUM

Application Number

207148

Product Number

1

Dosage Form

-

Strength

EQ 10GM BASE/VIAL

Approval Date

2017-11-24

Regulatory Status

RX

2009
06 Feb
RX Application: 78593

Drug Name

SUMATRIPTAN SUCCINATE

Product Number

1

Dosage Form

-

Strength

EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)

Approval Date

2009-02-06

78593 / 1

Active Ingredient

SUMATRIPTAN SUCCINATE

Application Number

78593

Product Number

1

Dosage Form

-

Strength

EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)

Approval Date

2009-02-06

Regulatory Status

RX

2026
29 May
RX Application: 220787

Drug Name

ZAYNICH

Product Number

1

Dosage Form

-

Strength

EQ 2GM BASE/VIAL;1GM/VIAL

Approval Date

2026-05-29

220787 / 1

Active Ingredient

CEFEPIME HYDROCHLORIDE; ZIDEBACTAM

Application Number

220787

Product Number

1

Dosage Form

-

Strength

EQ 2GM BASE/VIAL;1GM/VIAL

Approval Date

2026-05-29

Regulatory Status

RX

Related Databases
  • FDA Inspections
    14 View
  • EDQM CEP
    16 View
  • KDMF
    0 View
  • Japan DMF
    2 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    120 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
31 total
  • RX
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ABIRATERONE ACETATE

Application Number

208380

Product Number

1

Active Ingredient

ABIRATERONE ACETATE

Dosage Form

-

Strength

250MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.